About Gammaa Extracts

Built in Sri Lanka for Global Medical

Gammaa Extracts is Sri Lanka’s first licenced medical cannabis cultivation and export company. Designed for EU-GMP readiness from day one, Gammaa brings together controlled cultivation, strategic infrastructure, and experienced leadership to build a pharmaceutical-grade platform for regulated international markets.

Built for trust and regulated export

Sri Lanka’s First Licened Export Platform

Designed for EU-GMP Readiness

100% Indoor First Facility

Led by Pharma, Hospital & Export Veterans

Our Vision

To establish Sri Lanka as a globally respected source of pharmaceutical-grade medical cannabis, where botanical heritage, cultivation science, and export excellence meet.

Our Mission

To become Asia’s most trusted medical cannabis exporter, offering purity with purpose, from the heart of Ceylon to the world.

Why Choose Gammaa

Built for Trust & Regulated Export

Global Standard Regulations

As a licence holder we are actively working with the Sri Lankan government authorities to ensure alignment with the highest standards in the industry.

Sri Lankan Cost Advantage

Lower labour and electricity costs support efficient production and stronger competitiveness.

EU-GMP Readiness

The facility and operating approach are designed for EU-GMP compliance from day one.

Ayurvedic-Origin Brand Story

A rare combination of Sri Lankan heritage, modern science, and international market relevance.

Key Milestones

The Groundwork Behind Gammaa

Licensing Groundwork
Completed

Unlimited Licence
Secured

Consultant Platform
Established

International
Relationships Initiated

Financed by 2
Leading Banking Institutions

BOI Site Secured &
Permanent Licence

Licensing Groundwork

Passed the licensing process after two years of dedicated groundwork and sustained lobbying; a process no competitor had navigated before.

Unrestricted Operating Licence

Obtained an unlimited licence for cultivation, research, seed production, large-scale operations, any form of value addition and distribution — unique in a global context.

Consultant Platform Established

AgCann and Sostanza Global were engaged as lead cultivation and processing consultants, bringing experience across four continents.

International Market Relationships

Built relationships with potential clients in the UK, Germany and Australia, with buy-back agreement structures developed to secure consistent future revenue.

Project Financing Confirmed

Project financing approval negotiated and received from Commercial Bank of Ceylon PLC and Hatton National Bank - Sri Lanka's two leading institutional lenders.

BOI Site Secured & Permanent Licence

A permanent licence was received from the Department of Ayurveda, connecting the company's operations to Sri Lanka's oldest and most respected botanical medical authority.

Our Process

From Genetics to Export-Ready Product

Step 1

Genetics & Tissue Culture

Selection, propagation planning, and tissue culture preparation for consistent plant material. Grounded in consultant support around tissue culture lab setup and micropropagation.

Step 2

Propagation & Indoor Cultivation

Controlled early-stage plant development under monitored conditions. Plants are grown in a controlled environment using advanced greenhouse technology and CEA principles.

Step 3

Irrigation, Fertigation & IPM

Advanced irrigation and fertigation systems are combined with integrated pest management for crop health and consistency.

Step 4

Harvest & Post-Harvest Handling

Harvesting, trimming, drying, curing, and post-harvest optimization supported by specialist cultivation consultants. The licence scope covers manufacture and value addition across multiple forms, supporting future product pathways.

Step 5

Packaging, Storage & Export

Final product handling is aligned to secure storage, distribution, and export-oriented operations.

License Document Preview

License Number

RCC4034/24/PL

Type

Permanent Licence

Issuing Authority

Ayurveda Medicine & Production Regulatory Council

Brand Name

Ceylon Cannaleaf · Cannacare

Date of Issue

17 October 2025

Scope

Cultivate

Manufacture

Purchase

Store

Distribute

Sale

Export

Ayurvedic Products

Licence & Agreements

A Licence Scope Built for Scale

Gammaa’s current company materials present a licence scope covering cultivation, manufacture, purchase, storage, distribution, sale, export of cannabis and cannabis-related articles, substances or drugs, as well as Ayurvedic products. The deck also states that Gammaa holds one of the seven licences issued in Sri Lanka and has unlimited ability to produce and export medical cannabis in multiple forms.

One of seven licences in Sri Lanka

Broad scope across cultivation, manufacture, distribution & export

Permanent Department of Ayurveda licence also referenced in project milestones